Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Vaccines are one of the most successful and cost-effective public health tools for saving lives and preventing devastating illness, particularly among the children’s worldwide. Diseases that were once too common has now became rare predominantly due to prevalent immunization. Routine vaccination campaigns and programs by governments have prevented the deaths of hundreds of millions of people and has helped saved public health expenditures.
Increasing government focus on immunization programs, emerging new diseases and technological progress in vaccine administration has provoked research & development sector in industries to invent new and improved vaccine in future.
Developing focus on immunization programs, rising prevalence rate of infectious disease, increasing government support for vaccine development and growing use of adjuvants in vaccine are propelling the global vaccine market. However, high cost involved in manufacturing of vaccines is the major element responsible for drop in the vertical growth. Prolonged regulatory processes, delayed approval, stringent laws and market uncertainties are the major dynamics attributing to withdrawal of several drug manufacturing companies out of the vaccine vertical hampering innovation and development leading to shortage in vaccine supply.
The global vaccine market is segmented based on vaccine type, valance type, route of administration, indication type, patient type, distribution channel and geography.
Different type of vaccines studied in this vertical are live attenuated, inactivated & subunit, conjugate, toxoid and recombinant vaccines. Live attenuated vaccines are derived from diseases causing pathogens such as virus or bacteria. These pathogens are weakened by decreasing their virulence properties under laboratory condition.
Vaccines are categorized based upon their immunity against the number of pathogens such as monovalent and multivalent vaccines. Multivalent vaccines contain two or more strains of the same antigen whereas, monovalent consists of single strain from a single antigen.
Vaccines are designed to administer orally, can be injected and also, administered through intranasal spray application. They are often injected intramuscularly, subcutaneously and intradermally. Vaccines such as BCG vaccine is given through intradermal route to avoid the risk of neurovascular injury.
Vaccination is carried out for indications such as hepatitis, polio, varicella, diphtheria, pertussis, human papilloma virus, tetanus and influenza. Also, it is used against rotavirus, measles, mumps, and rubella, meningococcal & pneumococcal diseases.
Vaccinations are offered to pediatrics and adults. Traveler’s vaccines also called as travel immunization are given an individual before visiting certain areas of the world to avoid risk of getting serious illnesses.
Globally, vaccines are distributed to institutional sales, hospital pharmacies, retail pharmacies and clinics. It is predominantly used in hospital when vaccination period is announced.
Global vaccine market is analyzed across the various regions geographically including North America, Europe, Asia Pacific and rest of world. In 2018, the North America held the dominant position in this industry, due to rising incidence of both viral and bacterial infectious diseases coupled with increasing research & developmental activities by key market players in the region. Moreover, Asia pacific is expected to grow rapidly during the projection period 2019 to 2020, due to increasing prevalence of infectious diseases in the region.
The global vaccine market is segmented by vaccine type, valance type, route of administration, indication type, patient type, distribution channel and geography. Different type of vaccines studied in this vertical are live attenuated, inactivated & subunit, conjugate, toxoid and recombinant vaccines. Vaccines are categorized based upon their immunity against the number of pathogens such as monovalent and multivalent vaccines.
Vaccines are designed to administer orally, can be injected and also, administered through intranasal spray application. Vaccination is carried out for indications such as hepatitis, polio, varicella, diphtheria, pertussis, human papilloma virus, tetanus and influenza. Vaccinations are offered to pediatrics and adults.
Globally, vaccines are distributed to institutional sales, hospital pharmacies, retail pharmacies and clinics. The vaccine market is analyzed across the various regions geographically including North America, Europe, Asia Pacific and rest of world. In 2018, the North America held the dominant position in this industry, due to rising incidence of both viral and bacterial infectious diseases coupled with increasing research & developmental activities by key market players in the region.
Why to buy this report:
